CYFUSE BIOMEDICAL K K revenue for the last year amounted to 61.00 M JPY, the most of which — 42.90 M JPY — came from its highest performing source at the moment, Regenerative Medicine, the year earlier bringing 119.90 M JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought CYFUSE BIOMEDICAL K K 60.27 M JPY, and the year before that — 332.11 M JPY.